comparison of intervention with pain medication in the management of pain and improvement of quality of life in upper abdominal malignancy.

Comparison of intervention with analgesics versus analgesics alone in patients with upper abdominal malignancy in terms of pain relief and quality of life at 3 months follow up : A Prospective randomized study

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/06/014528

Enrollment

Registered

2018-06-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Upper abdominal cancer patient with moderate to severe pain presenting to pain clinic.

Interventions

Intervention1: Analgesic drugs(paracetamol,tramadol,morphine,fentanyl)adjuvant( gabapentin,duloxitene) and celiac plexus block intervention of celiac plexus: dose, frequency,and duration of the above

Eligibility

Inclusion criteria

Inclusion criteria: • Age more than 18 years • Either gender • Patients have agreed to participate in the study and have signed written informed consent. • Admitted in palliative care ward or attending Palliative care OPD at IRCH • NRS >4 (Moderate to severe pain) • Somatic, visceral or mixed pain

Exclusion criteria

Exclusion criteria: • Psychiatric disorder • Patients refusal to give consent to participate in the study • Patients with delirium or obtundation • Deranged coagulation profile

Design outcomes

Primary

Measure	Time frame
to assess the requirement of analgesics with or without intervention with celiac plexus block.Timepoint: 0 day/1st week/3rd week/8 week/12th week	—

Secondary

Measure	Time frame
To observe the difference in quality of life of patients with intervention and opioid or with opioid alone. Timepoint: 1,4,8,12 WEEKS	—

Countries

India

Contacts

Public ContactPreeti Singh

AIIMS NEW DELHI

Sushmabhatnagar1@gmail.com8368628183

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026